News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Best practices can make the lives of kids with cancer better – Childhood Cancer International
Childhood Cancer International/LinkedIn
Feb 19, 2025, 20:58

Best practices can make the lives of kids with cancer better – Childhood Cancer International

Childhood Cancer International shared a post on LinkedIn:

“Childhood Cancer is a rare disease by definition. Sharing our solutions can help others find the answers they are looking for. And taking a little bit of time to share our best practices can make the lives of kids with cancer better.

Join the campaign today! Learn more.”

Best practices can make the lives of kids with cancer better - Childhood Cancer International

More posts featuring Childhood Cancer International.

cancer Childhood Cancer International OncoDaily Oncology
Special Coverage
Oncolibrary
Jun 1, 2025, 13:02
CheckMate 214 Trial Final 9-Year Results at ASCO 2025: Nivolumab Plus Ipilimumab Continues to Show Long-Term Survival Benefit in Advanced Renal Cell Carcinoma
Oncolibrary
Jun 1, 2025, 12:40
Metacure Cohorts B2 Results: Intensified Hormonal Blockade and SBRT for PSMA-PET Detected Oligometastatic Prostate Adenocarcinoma
Oncolibrary
Jun 1, 2025, 12:03
EV-302 Updates at ASCO 2025: Enfortumab Vedotin Plus Pembrolizumab Doubles Complete Response Rate in Advanced Urothelial Carcinoma
Oncolibrary
Jun 1, 2025, 11:55
Tagitanlimab Boosts Chemotherapy in Nasopharyngeal Cancer: Phase 3 Results at ASCO 2025
Oncolibrary
Jun 1, 2025, 11:51
FIRE-4 Study Results: Cetuximab Re-challenge in Metastatic RAS Wild-Type Colorectal Cancer
Oncolibrary
Jun 1, 2025, 11:45
Combining Darolutamide and Goserelin: A New Frontier in Fighting Salivary Gland Cancer at ASCO 2025
Oncolibrary
Jun 1, 2025, 11:44
SURE-02 Phase 2 Trial Interim Results: Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab Shows Promising Bladder Preservation in Muscle-Invasive Bladder Cancer
Blog
Jun 1, 2025, 11:42
Estela Rodriguez: Day 2 ASCO25 Agenda
Blog
Jun 1, 2025, 11:35
Mario Balsa: Breaking from ASCO 2025 - DESTINY-Gastric04 Trial
Blog
Jun 1, 2025, 11:33
Cristiane Bergerot: Genomic Insights from IMmotion010
Oncolibrary
Jun 1, 2025, 11:24
CheckMate 901 Trial Final Results at ASCO 2025: Nivolumab + Ipilimumab Shows Durable Responses in Cisplatin-Ineligible Metastatic Urothelial Carcinoma
Blog
Jun 1, 2025, 11:07
Armando Orlandi: ASCO25 Breast Cancer Update, Early Data from May 30th Session